Chainbase vs Enzyme — how do they compare? Chainbase trades at Rp1,113 (market cap Rp430,29M, Rp56,3M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Chainbase is far larger — about 3.2× Enzyme's market cap, and Chainbase's supply is capped (387M / 1B C (39%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chainbase for 10 Days and Enzyme for 29 Days on average.
| C | MLN | |
|---|---|---|
Market Cap | Rp430,29M | Rp134,13M |
Volume (24h) | Rp56,3M | Rp104,56M |
Circulating Supply | 387M / 1B C (39%) | 3,3M MLN |
Typical Hold Time | 10 Days | 29 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →